Use of biofungicide Mycostop continues
Added on 21 February 2020
Health Canada has completed the re-evaluation of Streptomyces strain K61. Under the authority of the Pest Control Products Act, Health Canada has determined that continued registration of products containing Streptomyces strain K61 is considered to be acceptable. Following a scientific review of the available information, Health Canada has determined that the health and environmental risks and the value of Streptomyces strain K61 are continued to be acceptable provided that label amendments are implemented.
The pest control products (Mycostop biofungicide technical and Mycostop biofungicide), containing Streptomyces strain K61 that are registered in Canada, are subject to this re-evaluation decision.
Click here for more information.
Photo Courtesy of Labmanager
Source: Ag News
More news